Gearing Up for Potential Breakthroughs: FDA Evaluates Promising Drugs from Cytokinetics, Reata, Regeneron, Pfizer and GSK
February is set to be a pivotal month for drug approvals, with the FDA poised to deliver three critical decisions. One of these could be … Read more